checkAd

     113  0 Kommentare KalVista Pharmaceuticals Awarded UK Promising Innovative Medicine (PIM) Designation for Sebetralstat - Seite 3


    The KalVista Pharmaceuticals Stock at the time of publication of the news with a fall of -8,40 % to 12,00USD on Tradegate stock exchange (11. März 2024, 22:26 Uhr).

    Business Wire (engl.)
    0 Follower
    Autor folgen
    Seite 3 von 3

    KalVista Pharmaceuticals Awarded UK Promising Innovative Medicine (PIM) Designation for Sebetralstat - Seite 3 KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of oral, small molecule protease inhibitors, today announced the UK Medicines and Healthcare products …

    Auch bei Lesern beliebt

    Schreibe Deinen Kommentar

    Disclaimer